131P Targeting the m6A epitranscriptome affects cellular metabolism in ER-positive breast cancer cells and identifies a potential therapeutic vulnerability
Year: 2025
Type: article
Abstract: Metabolic alterations is a hallmark of human cancers as these changes provide the energy and biosynthetic precursors necessary for rapid proliferation. Multiple mechanisms underlie these changes, including epitranscriptomic N6-methyladenosine (m6A) modifications of RNA transcripts. We previously reported that an elevated m6A reader influences endocrine therapy (ET)-sensitivity and regulates enzymes involved in the serine synthesis pathway (SSP). Together, these findings suggest that targeting m6A modifications may differentially influence metabolism in ET-sensitive and ET-resistant ERα+ breast cancer (BC) cells.
Source: ESMO Open
Authors: M. Sumlut, C. Klinge, X. Yin, X. Zhang, B. Clem
Institution: University of Louisville
Language: English
Topic: RNA modifications and cancer
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,910
OpenAlex ID: W4410463564
